CL
REGN icon

Choreo LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Choreo LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.77M Buy
6,175
+743
+14% +$569K 0.06% 224
2025
Q4 		$4.2M Sell
5,432
-71
-1% -$48.2K 0.05% 224
2025
Q3 		$3.09M Buy
5,503
+533
+11% +$301K 0.04% 280
2025
Q2 		$2.61M Buy
4,970
+1,224
+33% +$683K 0.04% 305
2025
Q1 		$2.38M Buy
3,746
+32
+0.9% +$22K 0.04% 300
2024
Q4 		$2.62M Sell
3,714
-321
-8% -$269K 0.04% 289
2024
Q3 		$4.22M Buy
4,035
+250
+7% +$278K 0.06% 214
2024
Q2 		$4M Buy
3,785
+2,702
+249% +$2.62M 0.07% 191
2024
Q1 		$1.04M Buy
1,083
+36
+3% +$34.2K 0.03% 267
2023
Q4 		$920K Buy
+1,047
New +$862K 0.02% 278

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Choreo LLC's REGN Position: Q1 2026 in Review

Choreo LLC increased its Regeneron Pharmaceuticals (REGN) stake by 14% in Q1 2026, buying an estimated $569K and bringing the position to 6,175 shares worth $4.77M. The position accounts for 0.06% of the portfolio, ranked #224.

Choreo LLC first reported a position in REGN in Q4 2023 and has held it in 10 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Choreo LLC held 6,175 shares of Regeneron Pharmaceuticals worth $4.77M as of Q1 2026.
  • Choreo LLC bought 743 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $569K.
  • Regeneron Pharmaceuticals made up 0.06% of Choreo LLC's portfolio in Q1 2026, its #224 holding.
  • Choreo LLC first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.